CoreCap Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Buy |
7,372
+809
| +12% | +$55.8K | 0.02% | 510 |
|
|
2025
Q1 | $456K | Sell |
6,563
-464
| -7% | -$32.2K | 0.02% | 494 |
|
|
2024
Q4 | $604K | Sell |
7,027
-548
| -7% | -$47.1K | 0.03% | 430 |
|
|
2024
Q3 | $902K | Buy |
+7,575
| New | +$902K | 0.04% | 339 |
|
|
2024
Q2 | – | Sell |
-6,576
| Closed | -$844K | – | 2287 |
|
|
2024
Q1 | $844K | Buy |
+6,576
| New | +$844K | 0.04% | 317 |
|
|
2022
Q4 | $142K | Buy |
+2,094
| New | +$142K | 0.01% | 617 |
|
|
2022
Q3 | – | Sell |
-1,816
| Closed | -$101K | – | 1553 |
|
|
2022
Q2 | $101K | Buy |
+1,816
| New | +$101K | 0.01% | 681 |
|
|
2022
Q1 | – | Sell |
-1,996
| Closed | -$112K | – | 1546 |
|
|
2021
Q4 | $112K | Buy |
+1,996
| New | +$112K | 0.01% | 715 |
|